Therapeutic Targeting of RAS Mutant Cancers
BücherAngebote / Angebote:
The KRAS oncogene is believed to be the most common single nucleotide variant oncogene in human cancer. Historically, efforts to target KRAS and the other RAS GTPases have struggled. More recently, efforts have focused on identifying and exploiting features unique to specific oncogenic mutations.
Folgt in ca. 15 Arbeitstagen
Preis
30,50 CHFVerfügbarkeit:
LieferbarArtikel, die Sie kürzlich angesehen haben
Folgt in ca. 15 Arbeitstagen
217,00 CHF